For the year ending 2025-12-31, XBIO has $8,363,847 in assets. $968,025 in debts.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash | 7,883,632 | |||
| Prepaid expenses and other | 166,294 | |||
| Total current assets | 8,049,926 | |||
| Other assets | 313,921 | |||
| Total assets | 8,363,847 | |||
| Accounts payable | 258,109 | |||
| Accrued expenses and other current liabilities | 709,916 | |||
| Total current liabilities | 968,025 | |||
| Total liabilities | 968,025 | |||
| Preferred stock, value | 1,454 | |||
| Common stock, 0.001 par value 10,000,000 shares authorized as of december 31, 2025 and december 31, 2024 2,293,757 and 1,544,840 shares issued as of december 31, 2025 and december 31, 2024, respectively 2,291,056 and 1,542,139 shares outstanding as of december 31, 2025 and december 31, 2024, respectively | 2,294 | |||
| Additional paid in capital | 212,294,851 | |||
| Accumulated deficit | -199,875,331 | |||
| Accumulated other comprehensive income | 253,734 | |||
| Treasury stock | 5,281,180 | |||
| Total stockholders' equity | 7,395,822 | |||
| Total liabilities and stockholders' equity | 8,363,847 | |||
Xenetic Biosciences, Inc. (XBIO)
Xenetic Biosciences, Inc. (XBIO)